Immune Checkpoint Inhibitor-Induced Pancreatitis. (PubMed, United European Gastroenterol J) - Sep 8, 2026 - "All patients had received a combination ICI treatment (e.g., Ipilimumab + Nivolumab). Treatment of ICIPI should follow NCCN recommendations. The risk of developing a pancreatic exocrine insufficiency needs to be observed."
Checkpoint inhibition • Journal • Immunology • Oncology • Pancreatitis
|
|
Anne Hoorens; Atsuko Kasajima; Carlos Fernández Moro; Caroline S Verbeke; Celina Limbecker; Günter Klöppel; J-Matthias Löhr; Linnea Molander; Miroslav Vujasinovic; Suzane Ribeiro
|